INS and renal cell carcinoma: Whereas the experimental data on the role of insulin in RCC tumorigenesis are still limited [33], there is ample in vivo and in vitro data describing pro-proliferative and antiapoptotic properties of insulin together with insulin-like growth factor 1 (IGF1) [33–35].